Filing Details

Accession Number:
0001181431-13-059544
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-18 20:00:01
Reporting Period:
2013-11-14
Filing Date:
2013-11-18
Accepted Time:
2013-11-18 20:00:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1463729 Receptos Inc. RCPT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222012 Noubar Afeyan One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1255927 Jr M Edwin Kania One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1508052 Flagship Ventures Fund 2007, L.p. One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
1508053 Flagship Ventures 2007 General Partner Llc One Memorial Drive, 7Th Floor
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-14 155,583 $25.03 1,768,755 No 4 S Direct
Common Stock Disposition 2013-11-15 54,000 $24.20 1,714,755 No 4 S Direct
Common Stock Disposition 2013-11-15 904 $25.10 1,713,851 No 4 S Direct
Common Stock Disposition 2013-11-18 20,300 $24.09 1,693,551 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.50, inclusive. The reporting persons undertake to provide to Receptos Inc., any security holder of Receptos Inc., or the staff of the Securitites and Exchange Commision, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, and 3 to this Form 4.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.10 to $24.50, inclusive.
  3. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive.
  4. The shares of common stock are held by Flagship Ventures Fund 2007, L.P. ("Flagship Fund") The general partner of Flagship Fund is Flagship Ventures 2007 General Partner LLC ("Flagship GP"), and the managing members of Flagship GP are Noubar B. Afeyan Ph.D. and Edwin M. Kania, Jr. The General Partner and Messrs. Afeyan and Kania have voting and investment control over the shares held by Flagship Fund and may be deemed to be the beneficial owners of such shares and each of them disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.